Resivant Medical's Innovative Applicator for Cutiva™ PLUS Skin Closure System Secures U.S. Patent
Resivant Medical, based in Akron, Ohio, has achieved a significant milestone with the issuance of U.S. Patent No. 12,678,148. This patent protects a unique applicator that employs a single-lever mechanism, enabling clinicians to apply adhesive in a controlled manner during wound closure, thus enhancing both efficiency and precision in surgical procedures.
The innovation lies in the applicator's design, which allows surgeons to start, regulate, and stop the adhesive flow using one simple motion of their hand. Dr. David Kay, the founder of Resivant Medical, emphasizes that this level of control was not available prior, as the traditional means generally required repositioning of the device or hand, potentially complicating the process. The applicator design utilizes a pivoting lever that directly interacts with a glass ampoule, breaking it to dispense adhesive when pressed, and ceasing the flow upon release.
Paired with the Cutiva™ high-viscosity, no-run liquid adhesive, this system facilitates precise, intermittent dosing and guarantees a clean, single-handed application. Such features are essential for reliable wound closure, embodying the signatures of the Cutiva™ PLUS Skin Closure System, which has already received clearance from the U.S. Food and Drug Administration (FDA) and is being utilized in various healthcare settings across the country.
The approval of this patent not only underscores Resivant's commitment to innovation but also expands its intellectual property portfolio, which includes both existing and pending patents concerning their proprietary adhesive chemistry and advanced delivery technology. By focusing on developing next-generation medical adhesives, Resivant Medical aims to enhance wound closure for patients and streamline the workflow for healthcare professionals.
The Cutiva™ PLUS Skin Closure System is particularly notable as it aligns with the increasing demand for efficient and effective medical solutions. As medical practice evolves, tools that allow for improved surgical outcomes while minimizing the complexity of procedures are essential. The single-lever applicator holds the potential to transform how adhesives are applied in surgery, making it a crucial advancement for practitioners and patients alike.
For those interested in learning more about Resivant Medical and their innovative products, further information can be found on their website at www.resivant.com, or by contacting Lindsey Dinneen, the Director of Marketing Engagement at Project Medtech. This revolutionary breakthrough not only promises to change the landscape of wound closure but also represents an important step forward in enhancing medical technology overall.
The innovation lies in the applicator's design, which allows surgeons to start, regulate, and stop the adhesive flow using one simple motion of their hand. Dr. David Kay, the founder of Resivant Medical, emphasizes that this level of control was not available prior, as the traditional means generally required repositioning of the device or hand, potentially complicating the process. The applicator design utilizes a pivoting lever that directly interacts with a glass ampoule, breaking it to dispense adhesive when pressed, and ceasing the flow upon release.
Paired with the Cutiva™ high-viscosity, no-run liquid adhesive, this system facilitates precise, intermittent dosing and guarantees a clean, single-handed application. Such features are essential for reliable wound closure, embodying the signatures of the Cutiva™ PLUS Skin Closure System, which has already received clearance from the U.S. Food and Drug Administration (FDA) and is being utilized in various healthcare settings across the country.
The approval of this patent not only underscores Resivant's commitment to innovation but also expands its intellectual property portfolio, which includes both existing and pending patents concerning their proprietary adhesive chemistry and advanced delivery technology. By focusing on developing next-generation medical adhesives, Resivant Medical aims to enhance wound closure for patients and streamline the workflow for healthcare professionals.
The Cutiva™ PLUS Skin Closure System is particularly notable as it aligns with the increasing demand for efficient and effective medical solutions. As medical practice evolves, tools that allow for improved surgical outcomes while minimizing the complexity of procedures are essential. The single-lever applicator holds the potential to transform how adhesives are applied in surgery, making it a crucial advancement for practitioners and patients alike.
For those interested in learning more about Resivant Medical and their innovative products, further information can be found on their website at www.resivant.com, or by contacting Lindsey Dinneen, the Director of Marketing Engagement at Project Medtech. This revolutionary breakthrough not only promises to change the landscape of wound closure but also represents an important step forward in enhancing medical technology overall.
Topics Health）
【About Using Articles】
You can freely use the title and article content by linking to the page where the article is posted.
※ Images cannot be used.
【About Links】
Links are free to use.